The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
UDRdkzxd4LqW1kg2
